CD8A and prostate cancer: To investigate the impact of acute modulation of CD8+ T cell signaling on their immediate and post-re-expansion (distal) effector functions, we developed a novel and robust study system based on the use of allogeneic dendritic cells (DCs) and the prostate cancer cell line PC-3.